Mitochondrial quality control: Epigenetic signatures and therapeutic strategies

被引:18
|
作者
Ambekar, Tanuja [1 ]
Pawar, Jyoti [1 ]
Rathod, Ramdev [1 ]
Patel, Monica [1 ]
Fernandes, Valencia [1 ]
Kumar, Rahul [1 ]
Singh, Shashi Bala [1 ]
Khatri, Dharmendra Kumar [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res NIPER, Dept Pharmacol & Toxicol, Hyderabad 500037, Telangana, India
关键词
Neurodegeneration; Biogenesis; Mitophagy; Mitochondrial quality control; DNA methylation; Histone acetylation; COMPLEX-I; PARKINSONS-DISEASE; BIOGENESIS CONTRIBUTES; SUPEROXIDE-DISMUTASE; HUNTINGTONS-DISEASE; DNA METHYLATION; CELLULAR-MODEL; URSOLIC ACID; DYSFUNCTION; ACTIVATION;
D O I
10.1016/j.neuint.2021.105095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondria are semi-autonomous organelle staging a crucial role in cellular stress response, energy metabolism and cell survival. Maintaining mitochondrial quality control is very important for its homeostasis. Pathological conditions such as oxidative stress and neurodegeneration, disrupt this quality control, and involvement of genetic and epigenetic materials in this disruption have been reported. These regulatory factors trigger mitochondrial imbalance, as seen in many neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, and Huntington's disease. The dynamic regulatory pathways i.e. mitophagy, biogenesis, permeability pore transitioning, fusion-fission are affected as a consequence and have been reviewed in this article. Moreover, several epigenetic mechanisms such as DNA methylation and histone modulation participating in such neurological disorders have also been discussed. Apart from it, therapeutic approaches targeting mitochondrial quality control have been tremendously explored showing ameliorative effects for these diseases, and have been discussed here with a novel perspective.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis
    Zhang, Tianchi
    Wang, Lining
    Duan, Xiping
    Niu, Yuanyuan
    Li, Muzhe
    Yun, Li
    Sun, Haitao
    Ma, Yong
    Guo, Yang
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [32] Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke
    Meiying Song
    Yuan Zhou
    Xiang Fan
    Molecular Neurobiology, 2022, 59 : 3110 - 3123
  • [33] Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke
    Song, Meiying
    Zhou, Yuan
    Fan, Xiang
    MOLECULAR NEUROBIOLOGY, 2022, 59 (05) : 3110 - 3123
  • [34] Therapeutic Effects of Mesenchymal Stromal Cells Require Mitochondrial Transfer and Quality Control
    Mukkala, Avinash Naraiah
    Jerkic, Mirjana
    Khan, Zahra
    Szaszi, Katalin
    Kapus, Andras
    Rotstein, Ori
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
  • [35] Mitochondrial dynamics and mitochondrial quality control
    Ni, Hong-Min
    Williams, Jessica A.
    Ding, Wen-Xing
    REDOX BIOLOGY, 2015, 4 : 6 - 13
  • [36] Mitochondrial destabilization in tendinopathy and potential therapeutic strategies
    Cheng, Linxiang
    Zheng, Qiangqiang
    Qiu, Kaijie
    Ker, Dai Fei Elmer
    Chen, Xiao
    Yin, Zi
    JOURNAL OF ORTHOPAEDIC TRANSLATION, 2024, 49 : 49 - 61
  • [37] Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress
    Yamada, Yuma
    Takano, Yuta
    Satrialdi
    Abe, Jiro
    Hibino, Mitsue
    Harashima, Hideyoshi
    BIOMOLECULES, 2020, 10 (01)
  • [38] Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
    Huang, Yafei
    Zhou, Bingying
    BIOMEDICINES, 2023, 11 (05)
  • [39] Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
    Tranchese, Roberta Veglia
    Battista, Sabrina
    Cerchia, Laura
    Fedele, Monica
    BIOMOLECULES, 2024, 14 (11)
  • [40] TARGETING THE EPIGENETIC SIGNATURES AS EARLY EVENT FOR THE CONTROL OF TUMOR DEVELOPMENT
    Gupta, Krishna P.
    Pandey, Manuraj
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S696 - S696